At Novo Nordisk, we are driving change to defeat diabetes and other serious chronic conditions. Diabetes poses one of todayÍs biggest global health challenges. We work for a future where fewer people get diabetes, everyone with diabetes is diagnosed, and everyone who is diagnosed receives adequate treatment and can live a life with as few limitations as possible.
Since the company was founded in Denmark more than 90 years ago, we have been changing diabetes. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: haemophilia, growth disorders and obesity. Our ambition is to take the lead in each of these areas, driving change with an unfailing belief that it can be done.
This page isnÍt intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.
Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo NordiskÍs office in the country you live in: http://novonordisk.com/about_us/global_offices/global_offices.asp.
For other customer complaints please contact us here: http://novonordisk.com/about_us/contact_us/contact_us.asp
Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industries. Therefore, comments that pertain to legal matters or regulatory issues may be removed.
Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other Linkedin users.
Learn more about our community guidelines here http://bit.ly/NN-disclaimer
- Company Name:Novo Nordisk A/s
(View Trends)
-
Headquarters: (View Map)Bagsvaerd, Denmark
-
Pharmaceuticals
-
> 10,000 employees
- 168503 Global Rank
- 3882 Denmark
- 292 K Estimated Visits
-
Direct36.50%
-
Search32.96%
-
Social21.07%
-
Referrals8.45%
-
Mail1.00%
-
Display0.02%
-
36.63%
-
11.53%
-
8.66%
-
4.59%
- India 25.1%
- Saudi Arabia 16.6%
- Denmark 16.2%
- United States 5.9%
- Sweden 3.4%
- Biotechnology and Pharmaceuticals
- Pharmaceuticals
- 10 SDKs
- 3.0 Avg. Rating
- 5 Total reviews
- App Url: https://itunes.apple.com/app/novo-nordisk-1/id409407936
- App Support: http://www.CoagsUncomplicated.com
- Genre: Medical
- Bundle ID: com.novonordisk-us.novoseven
- App Size: 25.1 M
- Version: 2.5.0
- Release Date: December 18th, 2010
- Update Date: November 28th, 2017
Description:
Download the one-of-a-kind resource that can provide you with instant access to comprehensive bleeding disorder information anytime, anywhere. Coags Uncomplicated™ has helped put an expert bleeding disorder reference at the fingertips of >7000 healthcare professionals across >10 specialties ranging from hematology and oncology to critical care and pediatrics.
In a survey of 262 healthcare professionals who use Coags UncomplicatedTM:
-The app was rated 4.25 out of 5
-89% have used it as a reference in clinical decision making or case management
-Nearly 9 in 10 would recommend it to colleagues
Comprising lab patterns and thorough disease descriptions for dozens of bleeding disorders and blood tests, Coags UncomplicatedTM includes valuable tools to aid you in the identification of bleeding disorders. Features of the app include:
-Lab Value Analyzer: Enter lab results to receive a list of possible diagnoses to consider from a database of >60 bleeding disorders
-Diagnostic Algorithm: Begin with prothrombin time and activated partial thromboplastin time results, then narrow your differential diagnosis
-Neonatal Module: Receive specialized assistance to help you evaluate bleeding disorders in the neonatal population, where normal values are age sensitive
-Face a Case: Test your clinical skills with 5 case studies across a variety of bleeding disorders, both adult and pediatric
-Coag Challenge: Answer challenging bleeding disorder questions in an educational, fast-paced quiz
Designed for professionals by professionals, Coags UncomplicatedTM was developed by Novo Nordisk in partnership with key thought leaders in hematology and coagulation assays:
-Craig M. Kessler, MD, MACP, Professor of Medicine and Pathology, Director of the Coagulation Laboratory, Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, DC
-Ellinor I. Peerschke, PhD, FAHA, Vice Chair, Department of Laboratory Medicine, Head of Hematology and Coagulation Laboratory Services, Memorial Sloan-Kettering Cancer Center, New York, NY
-Meera B. Chitlur, MD, Associate Professor of Pediatrics, Wayne State University School of Medicine, Staff Physician, Division of Hematology/Oncology, Children’s Hospital of Michigan, Detroit, MI
-Roshni Kulkarni, MD, Professor of Pediatrics and Human Development, Director of Pediatric and Adolescent Hematology/Oncology, College of Human Medicine, Michigan State University, East Lansing, MI
Get Coags UncomplicatedTM today and discover the in-depth clinical information that thousands of healthcare professionals are already using.
Coags Uncomplicated™ is a reference tool. Clinical correlation and consultation with a hematologist are advised to ensure an accurate diagnosis.
Novo Nordisk Inc., 800 Scudders Mill Road, Plainsboro, New Jersey 08536 U.S.A.
Coags Uncomplicated™ is a trademark of Novo Nordisk Health Care AG.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
© 2013 Novo Nordisk All rights reserved. 1013-00018569-1 November 2013
Sort by
lilgreyk64
Bikingsuz
Usual application conflicts
Boricuagirl956
Excellent!!!
Gee2G
Coags
Dean0912
Pharm
-
Standard93.65%
-
Direct6.35%
They are headquartered at Bagsvaerd, Denmark, and have 2 advertising & marketing contacts listed on Kochava. Novo Nordisk A/s works with Advertising technology companies such as Videology, The Trade Desk, Chango, Dstillery, Turn, Neustar AdAdvisor, AOL-Time Warner Online Advertising, Media Innovation Group, Atlas, DoubleClick.Net, AppNexus, BlueKai, Resonate Insights, DemDex, Facebook Exchange FBX, AppNexus Segment Pixel, Yahoo Small Business, Facebook Custom Audiences, LinkedIn Ads, Bizo, Google Remarketing, Twitter Ads, DoubleClick Bid Manager, Adobe Audience Manager.
Collecting personal data